Chemical Structure : AML874
Catalog No.: PC-28771Not For Human Use, Lab Use Only.
AML874 is a potent selective CDK8/CDK19 inhibitor with IC50 of 62 nM (CDK8), targets the Mediator complex and disrupts Mediator-dependent transcription, shows selective anti-leukemic activity.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
AML874 is a potent selective CDK8/CDK19 inhibitor with IC50 of 62 nM (CDK8), targets the Mediator complex and disrupts Mediator-dependent transcription, shows selective anti-leukemic activity.
AML874 exerts its anti-leukemic activity by inducing apoptosis rather than triggering cellular differentiation.
AML874 induces dose-dependent decrease in phospho-STAT1 levels in IFN-high KG-1 cells.
AML874 synergized with venetoclax in AML cell lines and patient-derived xenograft models, resulting in enhanced anti-leukemic activity in vivo.
| M.Wt | 321.38 | |
| Formula | C19H19N3O2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Aitchedji C, et al. Leukemia. 2026 Nov 11. doi: 10.1038/s41375-026-03173-0.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright